"It is not a certificate you purchase. It is a designation you earn."
A formal, assessed, three-year institutional designation distinguishing your hospital, department, or specialist centre in every market you serve — awarded following independent assessment against six internationally aligned quality domains.
An independent international professional society with a federation of national bodies, a global expert network, and a thirteen-year track record.
The EUSTM Centre of Excellence designation is awarded following an independent assessment conducted by EUSTM specialist expert panels against clearly defined criteria. Institutions that achieve it have demonstrated — not merely claimed — that their quality systems, research infrastructure, clinical governance, and patient safety culture meet a standard that distinguishes them internationally.
Three tiers recognise different organisational types and contexts — making the programme accessible to whole hospital groups, individual clinical departments, and specialist standalone facilities.
For private hospitals, public hospitals, and academic medical centres assessed across all six quality domains. The most comprehensive designation — the strongest signal of institutional excellence available through the EUSTM programme.
For individual clinical departments within a hospital or academic institution — cardiology, oncology, surgical, ICU, emergency departments, and others. CME & Staff Development, Patient Safety Culture, and Clinical Governance are required for all department designations.
For standalone specialist facilities — IVF and fertility clinics, oncology centres, dialysis and renal care centres, cardiac rehabilitation centres, diagnostic imaging centres, day surgery centres, physiotherapy centres, and specialist outpatient clinics.
Every assessment is organised across six internationally aligned quality domains. Each tier is evaluated against a different combination, so the assessment fits the organisation's type and size — each domain below notes where it is required or optional.
Dedicated research team, active IRB-approved research activity, and at least one active clinical study or protocol in the preceding 12 months.
Required for Tier 1 · optional for Tiers 2 & 3Formal research-to-protocol pathway, biomarker capability, or active engagement with translational research networks.
Required for Tier 1 · optional for Tier 2 · not applicable to Tier 3Structured continuing medical education programme, CPD compliance tracking, and evidence of annual educational activity across clinical grades.
Required for all three tiersFormal incident reporting system, quarterly safety committee activity, root cause analysis capability, and evidence of closed-loop learning.
Required for all three tiersAt least one active MoU or formal collaboration with an international academic, clinical, or research institution.
Required for Tier 1 · optional for Tiers 2 & 3Clinical audit cycle in operation, governance committee with defined terms of reference, and quality KPI reporting at departmental or executive level.
Required for all three tiersStructured, transparent, and based on documented evidence — not subjective impressions. Typical timeline: eight to twelve weeks from application to designation decision.
Submit a self-assessment against domain criteria, supporting documentation, and organisational profile. EUSTM confirms eligibility within ten business days.
EUSTM assessors review policies, audit records, research protocols, staff education records, governance committee minutes, and quality data.
Structured virtual session (2–3 hours) with the medical director, clinical leads, and governance team. An on-site visit is available for Tier 1 on request.
Written report issued within 15 business days. Decision: Designation Awarded, Awarded with Conditions (90-day action period), or Not Yet Ready.
Certificate, digital designation mark and usage guidelines, EUSTM website listing, and a formal award letter. Valid for three years.
A brief annual maintenance report in years two and three confirming continued compliance, with a renewal assessment in year three.
Institutions that hold the EUSTM Centre of Excellence designation report using it across six key areas.
Signals to prospective clinical staff that the institution meets internationally recognised quality standards — a differentiator in competitive specialist recruitment markets.
For hospitals and specialist clinics serving international or premium domestic patients, it provides independent quality evidence that no internally produced marketing can replicate.
Institutions include the EUSTM CoE status in accreditation self-assessment submissions as evidence of independent third-party quality recognition.
Academic and research partners assess institutional quality when considering MoU arrangements — the designation provides credible, verifiable evidence.
Premium insurance panels increasingly require evidence of quality beyond basic licensing; the designation supports applications to premium payer networks.
Research departments cite the EUSTM CoE designation in grant applications as evidence of institutional research quality infrastructure.
The typical timeline from application to designation decision is eight to twelve weeks — covering document review, the virtual assessment visit, and a fifteen-business-day assessment report. Organisations with comprehensive documentation in place often complete the process at the lower end of this range.
Yes. A hospital may hold a Tier 1 hospital designation and additionally seek Tier 2 department designations for specific clinical departments. The assessments are conducted separately and the designations are independent of each other.
The assessment is designed to be constructive, not punitive. Institutions with gaps receive a "Designation Awarded with Conditions" outcome — with a defined action plan and a 90-day period to address the conditions. Institutions with more significant gaps receive a "Not Yet Ready" report with specific recommendations and are invited to reapply after an agreed preparation period.
Yes. The programme is open to eligible healthcare and research organisations worldwide. Assessments are conducted virtually for international applicants, with optional on-site visits available for Tier 1 hospital assessments. EUSTM has supported institutions across Asia, the Gulf, and Africa.
The EUSTM Centre of Excellence designation is a professional society recognition programme — it is not a regulatory accreditation and is not a substitute for JCI, ACHS, or national ministry of health accreditation. It is a complementary distinction, comparable to specialty recognition programmes awarded by leading international medical societies. Many institutions hold both regulatory accreditation and the EUSTM CoE designation simultaneously.
In years two and three, designated institutions submit a brief annual maintenance report — typically four to six pages — confirming continued compliance, reporting significant organisational changes, and providing updated evidence where activities have evolved. The process is designed to be low-burden while keeping the designation current and credible.
The EUSTM Centre of Excellence designation is a professional society recognition programme awarded by the European Society for Translational Medicine. It is not a regulatory accreditation and does not substitute for national or international hospital licensing or statutory accreditation requirements, including those of JCI, ACHS, or national ministries of health. All third-party body names and marks are the property of their respective owners; EUSTM is independent and not affiliated with, authorised by, or endorsed by any of them. This programme is advisory and recognition in nature and does not constitute clinical, medical, or legal advice.